You are here » Home » Company » Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd.

BSE: 500124 Sector: Health care
NSE: DRREDDY ISIN Code: INE089A01023
BSE 00:00 | 17 May 5251.25 55.40
(1.07%)
OPEN

5286.75

HIGH

5286.75

LOW

5143.50

NSE 00:00 | 17 May 5250.30 53.45
(1.03%)
OPEN

5250.00

HIGH

5260.00

LOW

5145.00

OPEN 5286.75
PREVIOUS CLOSE 5195.85
VOLUME 66143
52-Week high 5514.65
52-Week low 3613.45
P/E 39.94
Mkt Cap.(Rs cr) 87,328
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 5286.75
CLOSE 5195.85
VOLUME 66143
52-Week high 5514.65
52-Week low 3613.45
P/E 39.94
Mkt Cap.(Rs cr) 87,328
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Dr Reddys Laboratories Ltd.

Dr Reddys Laboratories Ltd

Dr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &Active Ingredients Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs) custom pharmac...> More

Dr Reddys Laboratories Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   87,328
EPS - TTM () [*S] 131.47
P/E Ratio (X) [*S] 39.94
Face Value ()   5
Latest Dividend (%)   500.00
Latest Dividend Date 13 Jul 2020
Dividend Yield (%) 0.48
Book Value / Share () [*S] 1021.26
P/B Ratio () [*S] 5.14
[*C] Consolidated     [*S] Standalone    

Dr Reddys Laboratories Ltd - Financial Results

Particulars ( cr) Mar 2021 Mar 2020 % Chg
Net Sales 4768.2 4448.9 7.18
Other Income 100.5 84.1 19.5
Total Income 4868.7 4533 7.41
Total Expenses 3715 3499.7 6.15
Operating Profit 1153.7 1033.3 11.65
Net Profit 557.3 781.1 -28.65
Equity Capital 83.2 83.1 -
> More on Dr Reddys Laboratories Ltd Financials Results

Dr Reddys Laboratories Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Sun Pharma.Inds. 686.95 -0.60 164819.91
Divi's Lab. 4043.20 0.53 107326.74
Dr Reddy's Labs 5251.25 1.07 87328.29
Cipla 881.05 -2.55 71052.27
Cadila Health. 611.60 -0.89 62609.49
Aurobindo Pharma 1002.10 -0.45 58713.04
> More on Dr Reddys Laboratories Ltd Peer Group

Dr Reddys Laboratories Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 26.74
Banks/FIs 0.08
FIIs 29.03
Insurance 0.86
Mutual Funds 13.31
Indian Public 8.31
Custodians 0.35
Other 20.68
> More on Dr Reddys Laboratories Ltd Share Holding Pattern

Dr Reddys Laboratories Ltd - Research Reports

Date Broker Action Price Report
25/09/2020 Prabhudas Lilladher Accumulate 5108 PDF IconDetails
16/09/2020 HDFC Securities Accumulate 4364 PDF IconDetails
08/09/2020 Emkay Global Hold 4431 PDF IconDetails
31/07/2020 HDFC Securities Reduce 4302 PDF IconDetails
21/05/2020 HDFC Securities Reduce 3910 PDF IconDetails
> More on Dr Reddys Laboratories Ltd Research Reports

Dr Reddys Laboratories Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -1.46% -1.45% 0.16% -0.13%
1 Month 7.32% 7.30% 1.53% 2.09%
3 Month 14.12% 14.12% -4.11% -1.88%
6 Month 9.74% 9.74% 12.80% 15.92%
1 Year 40.64% 40.57% 59.44% 63.33%
3 Year 165.21% 165.55% 41.06% 39.69%

Dr Reddys Laboratories Ltd - STOCK STRENGTH

Today's Low/High 5143.50
5286.75
Week Low/High 5143.50
5422.00
Month Low/High 4805.35
5422.00
YEAR Low/High 3613.45
5515.00
All TIME Low/High 3.83
5515.00
.